AUS
NZ
UK
CA
USA
IND
Highlights:
-
Talkiatry has introduced a new initiative to support women experiencing postpartum depression (PPD) through virtual appointments with board-certified psychiatrists.
-
The company has launched educational resources to help identify PPD symptoms and facilitate the scheduling of virtual consultations.
-
Talkiatry’s telehealth services are available through over 60 health insurance plans across 43 states, ensuring new patients can receive care within days of making an appointment.
Talkiatry, a Sage Therapeutics {NASDAQ:SAGE} prominent provider of in-network psychiatric care, has unveiled a new initiative aimed at enhancing support for women facing postpartum depression (PPD). This program seeks to improve access to mental healthcare for new mothers by offering virtual appointments with board-certified psychiatrists.
Recognizing that approximately one in eight new mothers in the United States report experiencing symptoms of PPD, Talkiatry aims to address the challenges associated with accessing timely care. The shortage of psychiatrists and lengthy wait times have made it difficult for many women to receive the help they need. To combat these barriers, Talkiatry has developed a telehealth solution in collaboration with Biogen Inc. (Nasdaq:BIIB), focusing specifically on maternal mental health.
The newly launched PPD page on Talkiatry's website serves as a comprehensive resource for women, featuring educational materials, an online assessment tool, and a user-friendly scheduling system for consultations with psychiatrists. With a commitment to accessible care, Talkiatry offers virtual psychiatry and therapy services that are covered by over 60 health insurance plans across 43 states, allowing new patients to be seen within days of scheduling an appointment. This initiative represents a significant step forward in addressing the critical need for timely and effective mental health support for new mothers.
